
Fleury S.A.
FLRY3 · SA · Healthcare / Diagnostics & Research
21.20BRL+0.15 (+0.71%)
Price History
Full chartMarket Stats
Previous Close21.05
Open21.03
Day Range20.88 – 21.37
52-Week Range13.01 – 23.95
Volume2.94M
Market Cap12.78B
P/E (TTM)20.26
Forward P/E12.29
EPS1.16
Dividend Yield6.76%
Beta0.21
50-Day Avg19.50
200-Day Avg16.87
About
Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medicine, orthopedics, ophthalmology, toxicological tests, fertility, infusions, and others. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.
Company Details
- SectorHealthcare
- IndustryDiagnostics & Research
- CEOMs. Jeane Mike Tsutsui
- Employees28.00K
- HeadquartersAvenida Morumbi, São Paulo, SP, Brazil, 04703-003, Brazil
- Websitehttps://ri.fleury.com.br
Leadership
- Ms. Jeane Mike TsutsuiCEO & President of Executive Board
- Mr. Jose Antonio de Almeida FilippoCFO & Member of Executive Board · b. 1960
- Mr. Edgar Gil RizzattiMedical, Technical & Process Executive Director and Member of Executive Board
- Mr. Roberto Santoro MeirellesL2L & Operations Support Officer and Member of Executive Board
- Ms. Patricia Yumi Maeda BertoncelloExecutive Director of Service Units & Member of Executive Board
- Angelica Dente de MenezesSecretary
- Mr. Renato de Oliveira BraunInvestor Relations Director
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap12.78B
Enterprise Value15.16B
Trailing P/E20.26
Forward P/E12.29
PEG Ratio9.91
Price / Sales1.45
Price / Book2.31
EPS1.16
Book Value9.18
Revenue (TTM)8.79B
Gross Profit (TTM)2.38B
EBITDA1.98B
Profit Margin8.01%
Operating Margin17.14%
Return on Equity12.62%
Return on Assets6.47%
Shares Outstanding543.63M
Shares Float241.71M
Beta0.21
Dividend Yield6.76%
Dividend Rate1.61
Payout Ratio90.72%
Dividends
20261×
0.40Aug 11, 2026
20253×
0.77Dec 2, 20250.31Aug 12, 20250.47Mar 6, 2025
20243×
0.21Dec 13, 20240.34Aug 14, 20240.15Mar 19, 2024
20232×
0.27Dec 15, 20230.17Sep 4, 2023
20222×
0.29Dec 19, 20220.71Mar 22, 2022
20214×
0.09Dec 20, 20210.13Aug 3, 20210.49Mar 2, 20210.23Jan 6, 2021
20202×
0.62Feb 26, 20200.11Jan 2, 2020
20193×
0.20Jul 30, 20190.69Mar 6, 20190.13Jan 2, 2019
20183×
0.18Jul 31, 20180.65Mar 6, 20180.13Jan 2, 2018
20171×
0.19Aug 1, 2017
Stock Splits
- Jun 13, 202321:20
- Jun 27, 20172:1